Related Experiment Video
Updated: Aug 14, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2
Nerea Allende-Vega1, Sylvia Dias, Diane Milne
1Molecular Signalling Group, Biomedical Research Centre, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Abstract:
The Murine double-minute clone 2 (Mdm2) onco-protein is the principal regulator of the tumour suppressor, p53. Mdm2 acts as an E3-type ubiquitin ligase that mediates the ubiquitylation and turnover of p53 under normal, unstressed circumstances. In response to cellular stress, such as DNA damage, the Mdm2-p53 interaction is disrupted. Part of the mechanism of uncoupling p53 from Mdm2-mediated degradation involves hypo-phosphorylation of a cluster of phosphorylated serine residues in the central acidic domain of Mdm2. Here, we show that two of the residues within this domain that are phosphorylated in vivo, Ser-260 and Ser-269, are phosphorylated by CK2 in vitro. Treatment of cells with the CK2 inhibitor, 4,5,6,7-tetrabromo-2-azabenzimidazole (TBB), leads to the induction of p53 and downstream targets of p53 including Mdm2 itself and p21. These data are consistent with the idea that CK2-mediated phosphorylation of Mdm2 may regulate Mdm2-mediated p53 turnover.
Insights
The study reveals that CK2 phosphorylates Mdm2 at specific sites, influencing its interaction with the tumor suppressor p53. Inhibiting CK2 with TBB increases p53 levels, suggesting a role for CK2 in regulating p53 turnover.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Signaling
Background:
- The Murine double-minute clone 2 (Mdm2) oncoprotein regulates the tumor suppressor p53.
- Mdm2 functions as an E3 ubiquitin ligase, targeting p53 for degradation under normal conditions.
- Cellular stress disrupts the Mdm2-p53 interaction, partly via Mdm2 hypo-phosphorylation.
Purpose of the Study:
- To investigate the role of CK2 in phosphorylating Mdm2.
- To determine if CK2-mediated Mdm2 phosphorylation affects p53 turnover.
Main Methods:
- In vitro phosphorylation assays using CK2 and Mdm2.
- Cellular treatment with the CK2 inhibitor 4,5,6,7-tetrabromo-2-azabenzimidazole (TBB).
- Analysis of p53 and downstream target (Mdm2, p21) levels via Western blotting or similar techniques.
Main Results:
- CK2 phosphorylates Mdm2 at Ser-260 and Ser-269 in vitro.
- TBB treatment induced p53 and its downstream targets, Mdm2 and p21.
- Hypo-phosphorylation of Mdm2 may be involved in uncoupling p53 from Mdm2-mediated degradation.
Conclusions:
- CK2-mediated phosphorylation of Mdm2 at Ser-260 and Ser-269 is demonstrated.
- Inhibition of CK2 leads to p53 accumulation, suggesting CK2's role in regulating p53 stability.
- These findings highlight a novel regulatory mechanism for the Mdm2-p53 axis in cancer biology.
Related Concept Videos
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex
Abnormal Proliferation
Positive Regulator Molecules
Positive Regulator Molecules

